Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 4CNS 4Thoracic 1Other solid neoplasm 1Head & Neck 1Gastrointestinal 1Endocrine 1Dermatologic 1

Conditions

Melanoma 36Carcinoma, Non-Small-Cell Lung 8Neoplasms 6Colorectal Neoplasms 6Carcinoma, Renal Cell 5Breast Neoplasms 5Stomach Neoplasms 4Neoplasm Metastasis 4Lymphoma, Follicular 4Uveal Melanoma 3Squamous Cell Carcinoma of Head and Neck 3Skin Neoplasms 3Prostatic Neoplasms 3Ovarian Neoplasms 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, Non-Hodgkin 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Carcinoma, Ovarian Epithelial 3Carcinoma, Merkel Cell 3Thyroid Neoplasms 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pancreatic Neoplasms 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell, Marginal Zone 2Lung Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hodgkin Disease 2

Interventions

cediranib 1carboxyamido-triazole 1Vinblastine 1Thalidomide 1Paclitaxel 1Introns 1Immunologic Techniques 1Fentanyl 1Docetaxel 1Dacarbazine 1Cisplatin 1Antimony Sodium Gluconate 190Y-octreotide, DOTA-Tyr(3)- 14-boronophenylalanine-fructose 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gliosarcoma × Cisplatin × Dermatologic × Clear all
NCT00498979 2020-07-24

Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers

Case Comprehensive Cancer Center

Phase 1 Completed
22 enrolled
CNSDermatologicSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Melanoma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡